Norway vs United States of America: Proportion of isolates with resistance to azithromycin reported to
Norway
7.6
in 2020
United States of America
5.8
in 2020
Norway rank
23rd
United States of America rank
26th
Proportion of isolates with resistance to azithromycin reported to over time
- Norway
- United States of America
How they compare
Norway currently reports 7.6 against 5.8 in United States of America, a difference of 1.8.
That makes Norway's figure about 1.3 times United States of America's.
Across all 11 years both countries report, Norway has been ahead every year.
Norway ranks 23rd and United States of America ranks 26th of 47 countries.
Norway has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Norway | United States of America | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.82 | 0.2131 | 1.61 | Norway |
| 2010s | 13.04 | 2.13 | 10.91 | Norway |
| 2020s | 7.6 | 5.8 | 1.8 | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with resistance to azithromycin reported to, Norway or United States of America?
- Norway, at 7.6 against 5.8 in United States of America as of 2020.
- What is the difference in proportion of isolates with resistance to azithromycin reported to between Norway and United States of America?
- 1.8, with Norway ahead.
- How many years of comparable data are there for Norway and United States of America?
- 11 years are reported by both, from 2009 to 2020.
- How do Norway and United States of America rank globally for proportion of isolates with resistance to azithromycin reported to?
- Norway ranks 23rd and United States of America ranks 26th of 47 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with resistance to azithromycin reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.